Monitor the filing of the Form S-4 registration statement for detailed financial projections and pro forma data. Watch for Planet 13 stockholder vote and regulatory approvals. The stock may trade on integration risks and near-term dilution until closing clarity emerges.
How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Jul 27 $9.70entry
- T+1 · 4mo ago −1.65%α −1.89% · $9.54
- T+5 · 4mo ago −0.93%α −3.44% · $9.61
- T+20 · 3mo ago +12.27%α +8.97% · $10.89
- T+60 · 28d ago −7.53%α −12.00% · $8.97
Price Chart
How similar events traded
Executive Summary
Vireo Growth Inc. announced a definitive merger agreement to acquire Planet 13 Holdings Inc., adding 36 dispensaries and significant cultivation capacity in Nevada, Florida, and Illinois. The all-stock deal implies a 16.6% premium over Planet 13's 20-day VWAP and will make Vireo the largest U.S. cannabis operator by dispensary count post-closing. The transaction is subject to Planet 13 stockholder approval, regulatory approvals, and SEC effectiveness of the Form S-4.
Key Facts
- Definitive merger agreement to acquire all of Planet 13 Holdings Inc. (CSE: PLTH, OTCQX: PLNH)
- Each Planet 13 share converts into 0.015383618 Vireo subordinate voting shares
- 16.6% premium over Planet 13's 20-day VWAP and 24% premium over closing price as of July 24, 2026
- Adds 36 dispensaries, ~45,000 sq ft active cultivation in Nevada, plus 2.3M sq ft expandable facilities, and ~76,000 sq ft cultivation in Florida
- Pro forma Vireo expected to operate ~265 dispensaries across 15 states
- Termination fee of US$1,800,000 payable by Planet 13 in certain circumstances
- Subject to Planet 13 stockholder approval, SEC Form S-4 effectiveness, CSE listing, and cannabis regulatory approvals
Financial Impact
All-stock transaction with no disclosed dollar value; exchange ratio implies premium over Planet 13's recent trading prices. Pro forma scale increase but dilution for Vireo shareholders.
Risk Factors
- Planet 13 stockholder approval not guaranteed; potential for a superior proposal despite termination fee
- SEC review of Form S-4 and effectiveness timeline uncertainty
- Regulatory hurdles under state cannabis laws and CSE listing approval
- Integration risks across multiple states and operational complexity
- Dilution for Vireo shareholders from stock issuance in a market with bearish consensus
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001104659-26-086874 |
| Document: tm2621363d1_8k.htm | 0001104659-26-086874 |
| Document: 0001104659-26-086874-index-headers.html | 0001104659-26-086874 |
| Document: 0001104659-26-086874-index.html | 0001104659-26-086874 |
| Document: 0001104659-26-086874.txt | 0001104659-26-086874 |
Track record
21 reports on VREOF
2 of 3 bullish or bearish reports moved the stock their way by T+60. Best: +18.71% at T+60 after the Jun 18, 2026 report. 3 of 4 went positive at some point.
Filters
- Nov 13, 20263d ago 3 Neutral 3/10 Entry $6.13 Now $6.29 +2.68% settles Feb 11
- Nov 13, 20263d ago 3 Neutral 2/10 Entry $6.13 Now $6.29 +2.68% settles Feb 11
- Nov 10, 20266d ago SC 13D/A Neutral 4/10 Entry $6.74 Now $6.29 −6.68% settles Feb 9
- Nov 10, 20266d ago 8-K Neutral 5/10 Entry $6.68 Now $6.29 −5.84% settles Feb 8
- Nov 3, 202614d ago EFFECT Neutral 4/10 Entry $7.45 Now $6.29 −15.57% settles Feb 1
- Oct 30, 202617d ago S-4/A Neutral 5/10 Entry $7.36 Now $6.29 −14.54% settles Jan 29
- Oct 9, 20265w ago S-4 Neutral 5/10 Entry $9.15 Now $6.29 −31.23% settles Jan 7
- Oct 8, 20265w ago 8-K Bullish 6/10 Entry $9.38 Now $6.29 −32.94% settles Jan 6
- Aug 18, 202612w ago 8-K Neutral 3/10 Entry $10.97 to $6.79 Now $6.29 −42.66% ▼ −38.10% −37.28% vs SPY
- Aug 11, 202613w ago 8-K Mixed 6/10 Entry $10.64 to $7.36 Now $6.29 −40.88% ▼ −30.83% −30.69% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers